About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Chicago | 112 Studies

Clinical Trials COPDChicago

COPD Clinical Trials in Chicago

Find 112 clinical trials for copd near Chicago, Illinois. Connect with research centers in your area.

All COPD trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 112 trials

CompletedPulmonary Vascular Changes in Early Chronic Obstructive PulmonaryThe Multi-Ethnic Study of Atherosclerosis (MESA) - Chronic Obstructive Pulmonary Disease (COPD) Study aims to characterize the pulmonary vascular changes and their biology in…NCT01397721·Alhambra, California and 3 others CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsThe purpose of this study is to compare a combination asthma drug (Symbicort) with its two components, budesonide and formoterol, taken individually or in combination, and with…NCT00206154·Birmingham, Alabama and 211 others

Page 1 of 6Next

COPD Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedThe CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad…NCT03581227·Los Angeles, California and 7 others

RecruitingPiMZ Longitudinal Cohort (PiMZ Logic)Alpha-1 Anti-trypsin Deficiency (AATD) is a genetic disease with lung and liver disease presentations.NCT06505603·Birmingham, Alabama and 4 others

CompletedComparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary DiseaseComparing the efficacy of Symbicort® pMDI and Formoterol Turbuhaler in reducing exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).NCT02157935·Andalusia, Alabama and 370 others

CompletedSafety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary DiseaseThis will be an open-label, non-randomized multi-center study designed to assess the safety and efficacy of Adipose-derived Stem Cell (ASC) IV implantation.NCT02216630·Davie, Florida and 4 others

CompletedThe CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)A prospective, multicenter study including a cross-section validation to define sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically…NCT03583099·Los Angeles, California and 8 others

RecruitingDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Depemokimab is being developed as a treatment for individuals with moderate to severe COPD.NCT06961214·Sheffield, Alabama and 192 others

CompletedObservational Study of Obstructive Lung Disease (NOVELTY)The NOVEL Observational longiTudinal studY (NOVELTY) is an observational study of obstructive lung disease and is a multi-country, multi-centre, prospective, longitudinal cohort…NCT02760329·Loma Linda, California and 330 others

CompletedBenralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryThe purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of…NCT02138916·Andalusia, Alabama and 406 others

CompletedComparative Effectiveness of a Peer-led O2 Infoline for Patients and CaregiversAbout 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life.NCT02098369·Lake Forest, California and 5 others

CompletedOptimizing Self-management COPD Treatment Through the American Lung Association HelplineAlthough self-management treatment improves quality of life among individuals with COPD, there is limited understanding of which elements of treatment are most effective.NCT05106257·Chicago, Illinois

CompletedADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations.NCT00144911·Birmingham, Alabama and 96 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDThe purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with…NCT00206167·Birmingham, Alabama and 215 others

CompletedStudy to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)This is a randomized, double-blind, multi-center, parallel-group study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations subjects with…NCT02465567·Andalusia, Alabama and 740 others

CompletedRespiratory Infection MonitoringThis study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential respiratory infections.NCT04362631·Chicago, Illinois

CompletedA Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6…NCT02727660·Dothan, Alabama and 281 others

CompletedRETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeThe study hypothesis is that symptomatic current and former smokers with spirometric values within the normal range (post-bronchodilator FEV1/FVC≥0.70 and post-BD FVC ≥ 70%…NCT02867761·Birmingham, Alabama and 15 others

WithdrawnThe Impact of Salmeterol-Fluticasone on Sleep in Patients With COPDThe purpose of this study is to determine if Advair Diskus improves sleep quality by reducing lung hyperinflation in COPD.NCT00741767·Chicago, Illinois

CompletedAn Observational Study of Beta-Blocker Use in Patients With COPD and Acute MIThe study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to…NCT04717492·Birmingham, Alabama and 23 others

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia